<!DOCTYPE html>
<html lang="en" dir="ltr">
  <head>
    <meta charset="utf-8">
    <title>INHIBITORS</title>
    <link rel="stylesheet" href="styletarget.css">
    <link rel="icon" href="favicon.ico">
  </head>
  <body bgcolor="#EEEDDE">
        <h1>Inhibitors list of Collagen α1 (I) (COL1A1) promotor</h1>
       <table border="4" bordercolor="#CE49BF" width=100%>
         <tr>
           <th>S.NO</th>
           <th>COMPOUND</th>
           <th>MOLECULAR FORMULA</th>
           <th>INHIBITION(IC50)</th>
           <th>SYNTHESIS</th>
           <th>REFERENCE ID</th>
         </tr>
         <tr>
           <td>1.</td>
           <td>12N-N0-(3-Chloro-5-trifluoromethoxyphenyl)carbamoylmethyl aloperine</td>
           <td>C24H30ClF3N3O2 [M + H]+</td>
           <td>8.4 ± 0.3</td>
           <td>Drug</td>
           <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663597/" target="_blank">Article Link</a></td>
         </tr>
         <tr>
           <td>2.</td>
           <td>12N-(N’-(Naphthalen-2-yl)-N’-phenyl)carbamoylmethyl aloperine</td>
           <td> C33H38N3O [M + H]+</td>
           <td>13.3 ± 0.5</td>
           <td>Drug</td>
           <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663597/" target="_blank">Article Link</a></td>
         </tr>
         <tr>
           <td>3.</td>
           <td>12N-N0-Phenoxazinylcarbamoylmethyl aloperine</td>
           <td> C29H34N3O2 [M + H]+</td>
           <td>16.5 ± 0.4</td>
           <td>Drug</td>
           <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663597/" target="_blank">Article Link</a></td>
         </tr>
       </table>
      </body>
    </html>
